Setouchi: A Vibrant Hub of Culture, Cuisine, and Experiences

SETOUCHI,Japan,March 11,2025-- The Setouchi region of Japan,made famous to an international audience by Donald Richie\'s exceptional The Inland Sea — a travelogue which has inspired millions since it

03-11

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity

BEIJING and BRIDGEWATER,N.J.,March 10,2025-- Gan & Lee Pharmaceuticals(Gan & Lee,Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a Phase 2

03-11

GigaMedia Announces Purchase of Convertible Note of Aeolus Robotics Corporation

TAIPEI,March 7,2025-- GigaMedia Limited (NASDAQ: GIGM) today announced that the Company has entered into and executed an agreement to purchase a US$2,600,000 principal amount of convertible promissory

03-10

SKF Annual Report 2024 published online; significant decarbonization milestone reached

GOTHENBURG,Sweden,March 7,2025-- ABSKF has today published its Annual and Sustainability Report 2024 on the Group\'s website. The Report focuses on SKF\'s value creation activities for customers,share

03-10

Ping An Tops Global Patentee Top 10 List, Leading in Fintech and Healthcare

Ping An ranks first in global patents in healthcare and fintech,according to two new reports from the Intellectual Property Publishing House.

03-10

BNBEX Exchange: Compliance operation and technological innovation parallel, all-round help investors profit

03-10

Baidu Announces Pricing of CNY10 Billion CNY-denominated Senior Notes

BEIJING,March 6,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)),("Baidu" or the "Company"),a leading AI company with strong Internet foundatio

03-06

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

PALMA DE MALLORCA,Spain,March 5,2025-- LaminarPharma,a leader in the development of innovative cancer therapy based on membrane lipid therapy,announced today optimistic results from its ongoing clini

03-06

J&T Express Achieved Full-Year Profit for the First Time in 2024 After Recording 15.9% in Revenue Growth

Southeast Asia market share climbed to 28.6%,China parcel volume growth outpaced industry HONG KONG,March 5,2025--J&T Global Express Limited ("J&T Express" or "J&T" or

03-06

EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing Non-Invasive Facial Lifting Procedure

PRAGUE,March 5,2025--EMFACE,the revolutionary non-invasive facial treatment,has reached an extraordinary milestone—becoming the fastest procedure of its kind to surpass 1 million treatments worldwide

03-06